Form D · Biotechnology
ARRAY BIOPHARMA INC
Boulder, CO · CIK 0001100412
Offering snapshot reported Aug 12, 2009 · SEC filing
- Reported sold
- $0 Indefinite offering
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- May 15, 2009 As reported in this filing
Fundraising history
Reported soldDates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 12, 2009 | Amendment | $0 | $0vs May 29, 2009 | 2 | SEC filing |
| May 29, 2009 | Initial | $0 | No comparison | Not reported | SEC filing |
| May 14, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-118338
Warrants issued for 6,000,000 shares of common stock at $4.19 per share. Warrants previously issued for 6,000,000 shares of common stock at $3.65 per share. Common stock issuable upon exercise of foregoing warrants
Source: Form D, filed Aug 12, 2009. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Francis J. Bullock | Director |
| R. Michael Carruthers | Executive |
| Marvin H. Caruthers | Director |
| Robert E. Conway | Director, Executive |
| Kevin Koch | Director, Executive |
| Kyle A. Lefkoff | Director |
| John R. Moore | Executive |
| David Snitnam | Director, Executive |
| Gil J. Van Lunsen | Director |
| Douglas E. Williams | Director |
| John L. Zabriskie | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:Boulder, CO, 80301